Temas de la conferencia
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale.
Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Adel Nada, CEO, GentiBio, Jeremie Mariau, CEO, ILTOO PHARMA, Jo Viney, Co-Founder, President and CSO, Pandion Therapeutics, Marc Martinez- Llordella, co-Founder and VP Biology, Quell Therapeutics and more.
Información e inscripción:
https://go.evvnt.com/710471-1?pid=4832
Mr. Treg Directed Therapies Summit Team
CategoríasMedicina General